Improving patients' quality of life by
developing novel medicines
Experts in cannabinoid application technologies
Echo Pharmaceuticals is an innovative technology-based pharmaceutical company located in the Netherlands. We are known for our first-class experience in extraction, purification, and formulation of lipophilic active compounds, particularly cannabinoids. Using our patented knowledge of drug formulation, we develop the optimized formulation of active pharmaceutical ingredients for clinical investigations and perform clinical trials.
Echo Pharmaceuticals’ proprietary knowledge and competences are in extracting and purifying arbitrary APIs from plant materials. Isolation takes place under controlled laboratory conditions, which guarantees the high quality of the purified API. As a result, we produce a wide range of cannabinoid standards for analytical purposes and two cannabinoid APIs, all produced under cGMP guidelines. Echo Pharmaceuticals supplies R&D organizations around the globe.
Our products and development programs focus on a product portfolio of drug delivery technologies and cannabinoid-based medicines
Products on Market
With the current growing demand for cannabinoids, we offer a wide range of high quality cannabinoid reference standards
Active Pharmaceutical Ingredients
Echo Pharmaceuticals is specialized in
the production of
cannabis-derived active pharmaceutical ingredients (API) which are commercially available. Additionally, these APIs are also currently used in clinical development.
Products in Clincial Development
Namisol is a patented oral tablet that contains pure, natural Δ9-THC, has a high and predictable bioavailability combined with a long and stable shelf life at room temperature.
Arvisol is a patented oral tablet that contains pure, natural Cannabidiol, has a high and predictable bioavailability combined with a long and stable shelf life at room temperature.